Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Momoko Kubo, Taro Kishi, Shinji Matsunaga, Nakao Iwata

Research output: Contribution to journalReview article

10 Citations (Scopus)


Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease. Methods: Relevant studies were identified through searches of PubMed ®, databases of the Cochrane Library

Original languageEnglish
Pages (from-to)667-671
Number of pages5
JournalJournal of Alzheimer's Disease
Issue number3
Publication statusPublished - 01-10-2015


All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this